Bai, Hongsong
Jiang, Weixing
Wang, Dong
Shou, Jianzhong
Li, Changling
Xing, Nianzeng
Article History
Received: 14 February 2022
Accepted: 19 August 2022
First Online: 29 August 2022
Declarations
:
: Approval for this study was granted by the Ethics Committee of National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Written informed consent was obtained from all patients before administering treatment. All methods were performed following the relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.